Evidence map›Paper›PMID 32783937›Full record

ArticleCell reports2020

Protein O-GlcNAc Modification Links Dietary and Gut Microbial Cues to the Differentiation of Enteroendocrine L Cells.

Ming Zhao, Kaiqun Ren, Xiwen Xiong, Meng Cheng, Zengdi Zhang, Zan Huang, Xiaonan Han, Xiaoyong Yang, Emilyn U Alejandro, Hai-Bin Ruan

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. O-GlcNAc of STING mediates antiviral innate immunity.Cell communication and signaling : CCS · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Enteroendocrine System and Gut Barrier in Metabolic Disorders.International journal of molecular sciences · 2022
    Review
  18. Article
  19. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.Frontiers in cellular and infection microbiology · 2022
    Review
  20. A nexus of lipid andFrontiers in endocrinology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ming ZhaoDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Kaiqun RenDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; College of Medicine, Hunan Normal University, Changsha, Hunan 410013, China.
Xiwen XiongSchool of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China.
Meng ChengDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Zengdi ZhangDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Zan HuangDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Xiaonan HanDivision of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Xiaoyong YangDepartment of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT 06519, USA; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06519, USA.
Emilyn U AlejandroDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Hai-Bin RuanDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Center for Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA. Electronic address: hruan@umn.edu.
University of Minnesota Medical Center · USCincinnati Children's Hospital Medical Center · USHunan Normal University · CNXinxiang Medical University · CNYale University · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
O-GlcNAc Modification in Metabolic HomeostasisR01DK089098 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2010 to 2021
$3.0M
Protein O-GlcNAcylation in Regulatory T Cell FunctionR01AI139420 · NIAID · UNIVERSITY OF MINNESOTA · PI RUAN, HAI-BIN · 2019 to 2023
$2.3M
The role of O-linked N-Acetylglucosamine Homeostasis in Pancreatic Beta-cell Development and FunctionR01DK115720 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN · 2018 to 2022
$1.9M
O-GlcNAc Signaling in Central Control of Energy BalanceR01DK102648 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2016 to 2019
$1.8M
REGULATION OF NICHE CELL DIFFERENTIATION TO SUSTAIN INTESTINAL STEM CELL REGENERATION AGAINST GUT INFLAMMATIONR01DK123299 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI HAN, XIAONAN · 2020 to 2023
$1.4M
O-linked-N-acetylglucosamine Post-translational Modification in Pancreatic Beta-cells Regulating ER Stress and Mitochondrial FunctionR21DK112144 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN · 2017 to 2019
$576k
O-GlcNAc signaling enables the intestinal epithelial remodeling associated with type 2 immunityR21AI140109 · NIAID · UNIVERSITY OF MINNESOTA · PI RUAN, HAI-BIN · 2018 to 2019
$424k
NCI NIH HHS P30 CA077598NIAID NIH HHS R01 AI139420NIAID NIH HHS R21 AI140109NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK089098NIDDK NIH HHS R01 DK102648NIDDK NIH HHS R01 DK115720NIDDK NIH HHS R01 DK123299NIDDK NIH HHS R21 DK112144
6 · The paper itself

Abstract

Intestinal L cells regulate a wide range of metabolic processes, and L-cell dysfunction has been implicated in the pathogenesis of obesity and diabetes. However, it is incompletely understood how luminal signals are integrated to control the development of L cells. Here we show that food availability and gut microbiota-produced short-chain fatty acids control the posttranslational modification on intracellular proteins by O-linked β-N-acetylglucosamine (O-GlcNAc) in intestinal epithelial cells. Via FOXO1 O-GlcNAcylation, O-GlcNAc transferase (OGT) suppresses expression of the lineage-specifying transcription factor Neurogenin 3 and, thus, L cell differentiation from enteroendocrine progenitors. Intestinal epithelial ablation of OGT in mice not only causes L cell hyperplasia and increased secretion of glucagon-like peptide 1 (GLP-1) but also disrupts gut microbial compositions, which notably contributes to decreased weight gain and improved glycemic control. Our results identify intestinal epithelial O-GlcNAc signaling as a brake on L cell development and function in response to nutritional and microbial cues.

Indexed as

Cell DifferentiationDietGastrointestinal MicrobiomeAnimalsBasic Helix-Loop-Helix ProteinsCaco-2 CellsCuesEnteroendocrine CellsFatty Acids, VolatileForkhead Box Protein O1Glucagon-Like Peptide 1HumansIntestinal MucosaMiceN-AcetylglucosaminyltransferasesNerve Tissue ProteinsBasic Helix-Loop-Helix ProteinsFatty Acids, VolatileForkhead Box Protein O1Glucagon-Like Peptide 1N-AcetylglucosaminyltransferasesNerve Tissue ProteinsNeurog3 protein, mouseO-GlcNAc transferasediabetesGLP-1L cellsobesityO-GlcNAcshort-chain fatty acids

Identifiers

PMID32783937
PMCPMC7457433
OpenAlexW3048750884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.